Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etomidate infusion timing and postoperative adrenocortical function study
ChiCTR2400082034Phase 4Not yet recruiting
- Sponsor
- The First Affiliated Hospital of Wannan Medical College
- Start
- Mar 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of etomidate (2 cohorts), sponsored by The First Affiliated Hospital of Wannan Medical College. Primary endpoints: Serum cortisol concentration, Serum aldosterone concentration and 1 more. Planned start Mar 2024; status: not yet recruiting.
02
Drugs
etomidate
Beyond the preview
Go deeper on ChiCTR2400082034.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400082034.